Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome

Engraftment and differentiation of donor hematopoietic stem cells is decisive for the clinical success of allogeneic stem cell transplantation (alloSCT) and depends on the recipient’s bone marrow (BM) niche. A damaged niche contributes to poor graft function after alloSCT; however, the underlying me...

Full description

Saved in:
Bibliographic Details
Main Authors: Katzerke, Christiane (Author) , Schaffrath, Judith (Author) , Lützkendorf, Jana (Author) , Janssen, Maike (Author) , Merbach, Anne Kathrin (Author) , Nerger, Katrin (Author) , Binder, Mascha (Author) , Baum, Cornelia (Author) , Lauer, Kirstin (Author) , Rohde, Christian (Author) , Willscher, Edith (Author) , Müller-Tidow, Carsten (Author) , Müller, Lutz P. (Author)
Format: Article (Journal)
Language:English
Published: 27 June 2023
In: Blood advances
Year: 2023, Volume: 7, Issue: 12, Pages: 2811-2824
ISSN:2473-9537
DOI:10.1182/bloodadvances.2022008510
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/bloodadvances.2022008510
Resolving-System, kostenfrei: https://doi.org/10.25673/109917
Get full text
Author Notes:Christiane Katzerke, Judith Schaffrath, Jana Lützkendorf, Maike Janssen, Anne-Kathrin Merbach, Katrin Nerger, Mascha Binder, Cornelia Baum, Kirstin Lauer, Christian Rohde, Edith Willscher, Carsten Müller-Tidow, and Lutz P. Müller

MARC

LEADER 00000caa a2200000 c 4500
001 1854028618
003 DE-627
005 20240328081425.0
007 cr uuu---uuuuu
008 230801s2023 xx |||||o 00| ||eng c
024 7 |a 10.1182/bloodadvances.2022008510  |2 doi 
024 7 |a 10.25673/109917  |2 doi 
035 |a (DE-627)1854028618 
035 |a (DE-599)KXP1854028618 
035 |a (OCoLC)1425213881 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Katzerke, Christiane  |e VerfasserIn  |0 (DE-588)1297865863  |0 (DE-627)1854031686  |4 aut 
245 1 0 |a Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome  |c Christiane Katzerke, Judith Schaffrath, Jana Lützkendorf, Maike Janssen, Anne-Kathrin Merbach, Katrin Nerger, Mascha Binder, Cornelia Baum, Kirstin Lauer, Christian Rohde, Edith Willscher, Carsten Müller-Tidow, and Lutz P. Müller 
264 1 |c 27 June 2023 
300 |b Illustrationen 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Im Voraus online veröffentlicht in "Blood Advances First Edition": 10. Februar 2023, Artikelversion: 16. Juni 2023 
500 |a Gesehen am 01.08.2023 
520 |a Engraftment and differentiation of donor hematopoietic stem cells is decisive for the clinical success of allogeneic stem cell transplantation (alloSCT) and depends on the recipient’s bone marrow (BM) niche. A damaged niche contributes to poor graft function after alloSCT; however, the underlying mechanisms and the role of BM multipotent mesenchymal stromal cells (MSC) are ill-defined. Upon multivariate analysis in 732 individuals, we observed a reduced presence of proliferation-capable MSC in BM aspirates from patients (N = 196) who had undergone alloSCT. This was confirmed by paired analysis in 30 patients showing a higher frequency of samples with a lack of MSC presence post-alloSCT compared with pre-alloSCT. This reduced MSC presence was associated with reduced survival of patients after alloSCT and specifically with impaired graft function. Post-alloSCT MSC showed diminished in vitro proliferation along with a transcriptional antiproliferative signature, upregulation of epithelial-mesenchymal transition and extracellular matrix pathways, and altered impact on cytokine release upon contact with hematopoietic cells. To avoid in vitro culture bias, we isolated the CD146+/CD45-/HLA-DR- BM cell fraction, which comprised the entire MSC population. The post-alloSCT isolated native CD146+MSC showed a similar reduction in proliferation capacity and shared the same antiproliferative transcriptomic signature as for post-alloSCT colony-forming unit fibroblast-derived MSC. Taken together, our data show that alloSCT confers damage to the proliferative capacity of native MSC, which is associated with reduced patient survival after alloSCT and impaired engraftment of allogeneic hematopoiesis. These data represent the basis to elucidate mechanisms of BM niche reconstitution after alloSCT and its therapeutic manipulation. 
540 |q DE-3  |a Namensnennung - Nicht kommerziell - Keine Bearbeitungen 4.0 International  |f CC BY-NC-ND 4.0  |2 cc  |u https://creativecommons.org/licenses/by-nc-nd/4.0/ 
700 1 |a Schaffrath, Judith  |e VerfasserIn  |4 aut 
700 1 |a Lützkendorf, Jana  |e VerfasserIn  |4 aut 
700 1 |a Janssen, Maike  |e VerfasserIn  |0 (DE-588)1190667665  |0 (DE-627)166922645X  |4 aut 
700 1 |a Merbach, Anne Kathrin  |e VerfasserIn  |0 (DE-588)1297859014  |0 (DE-627)185402907X  |4 aut 
700 1 |a Nerger, Katrin  |e VerfasserIn  |4 aut 
700 1 |a Binder, Mascha  |e VerfasserIn  |4 aut 
700 1 |a Baum, Cornelia  |e VerfasserIn  |4 aut 
700 1 |a Lauer, Kirstin  |e VerfasserIn  |4 aut 
700 1 |a Rohde, Christian  |e VerfasserIn  |0 (DE-588)1164191675  |0 (DE-627)1028653816  |0 (DE-576)508428939  |4 aut 
700 1 |a Willscher, Edith  |e VerfasserIn  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Müller, Lutz P.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Blood advances  |d Washington, DC : American Society of Hematology, 2016  |g 7(2023), 12 vom: Juni, Seite 2811-2824  |h Online-Ressource  |w (DE-627)873588312  |w (DE-600)2876449-3  |w (DE-576)48043249X  |x 2473-9537  |7 nnas  |a Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome 
773 1 8 |g volume:7  |g year:2023  |g number:12  |g month:06  |g pages:2811-2824  |g extent:14  |a Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome 
856 4 0 |u https://doi.org/10.1182/bloodadvances.2022008510  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://doi.org/10.25673/109917  |x Resolving-System  |z kostenfrei 
951 |a AR 
992 |a 20230801 
993 |a Article 
994 |a 2023 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 12 
998 |g 1164191675  |a Rohde, Christian  |m 1164191675:Rohde, Christian  |d 910000  |d 910100  |e 910000PR1164191675  |e 910100PR1164191675  |k 0/910000/  |k 1/910000/910100/  |p 10 
998 |g 1297859014  |a Merbach, Anne Kathrin  |m 1297859014:Merbach, Anne Kathrin  |d 910000  |d 910100  |e 910000PM1297859014  |e 910100PM1297859014  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1190667665  |a Janssen, Maike  |m 1190667665:Janssen, Maike  |d 910000  |d 910100  |e 910000PJ1190667665  |e 910100PJ1190667665  |k 0/910000/  |k 1/910000/910100/  |p 4 
999 |a KXP-PPN1854028618  |e 4361734984 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"language":["eng"],"part":{"year":"2023","volume":"7","issue":"12","pages":"2811-2824","extent":"14","text":"7(2023), 12 vom: Juni, Seite 2811-2824"},"pubHistory":["Vol. 1, iss. 1 (November 2016)-"],"note":["Gesehen am 27.04.21"],"disp":"Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcomeBlood advances","type":{"bibl":"periodical","media":"Online-Ressource"},"name":{"displayForm":["American Society of Hematology"]},"recId":"873588312","title":[{"title":"Blood advances","title_sort":"Blood advances"}],"id":{"zdb":["2876449-3"],"eki":["873588312"],"issn":["2473-9537"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"[2016]-","publisher":"American Society of Hematology","publisherPlace":"Washington, DC"}]}],"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"27 June 2023"}],"title":[{"title_sort":"Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome","title":"Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"noteIll":"Illustrationen","extent":"14 S."}],"id":{"eki":["1854028618"],"doi":["10.1182/bloodadvances.2022008510","10.25673/109917"]},"recId":"1854028618","person":[{"role":"aut","family":"Katzerke","display":"Katzerke, Christiane","given":"Christiane"},{"family":"Schaffrath","role":"aut","given":"Judith","display":"Schaffrath, Judith"},{"role":"aut","family":"Lützkendorf","display":"Lützkendorf, Jana","given":"Jana"},{"display":"Janssen, Maike","given":"Maike","role":"aut","family":"Janssen"},{"family":"Merbach","role":"aut","given":"Anne Kathrin","display":"Merbach, Anne Kathrin"},{"display":"Nerger, Katrin","given":"Katrin","family":"Nerger","role":"aut"},{"family":"Binder","role":"aut","display":"Binder, Mascha","given":"Mascha"},{"given":"Cornelia","display":"Baum, Cornelia","family":"Baum","role":"aut"},{"role":"aut","family":"Lauer","given":"Kirstin","display":"Lauer, Kirstin"},{"family":"Rohde","role":"aut","given":"Christian","display":"Rohde, Christian"},{"display":"Willscher, Edith","given":"Edith","family":"Willscher","role":"aut"},{"family":"Müller-Tidow","role":"aut","given":"Carsten","display":"Müller-Tidow, Carsten"},{"given":"Lutz P.","display":"Müller, Lutz P.","role":"aut","family":"Müller"}],"note":["Im Voraus online veröffentlicht in \"Blood Advances First Edition\": 10. Februar 2023, Artikelversion: 16. Juni 2023","Gesehen am 01.08.2023"],"language":["eng"],"name":{"displayForm":["Christiane Katzerke, Judith Schaffrath, Jana Lützkendorf, Maike Janssen, Anne-Kathrin Merbach, Katrin Nerger, Mascha Binder, Cornelia Baum, Kirstin Lauer, Christian Rohde, Edith Willscher, Carsten Müller-Tidow, and Lutz P. Müller"]}} 
SRT |a KATZERKECHREDUCEDPRO2720